SCY vs. IN, IMV, OSS, HPQ, A, ZNG, PGZ, DAN, TK, and GENM
Should you be buying Scandium International Mining stock or one of its competitors? The main competitors of Scandium International Mining include InMed Pharmaceuticals (IN), IMV (IMV), OneSoft Solutions (OSS), HPQ Silicon (HPQ), Armor Minerals (A), Group Eleven Resources (ZNG), Pan Global Resources (PGZ), Arianne Phosphate (DAN), Tinka Resources (TK), and Generation Mining (GENM).
Scandium International Mining vs.
InMed Pharmaceuticals (TSE:IN) and Scandium International Mining (TSE:SCY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.
InMed Pharmaceuticals' return on equity of 0.00% beat Scandium International Mining's return on equity.
Scandium International Mining has lower revenue, but higher earnings than InMed Pharmaceuticals.
Scandium International Mining received 93 more outperform votes than InMed Pharmaceuticals when rated by MarketBeat users. However, 77.78% of users gave InMed Pharmaceuticals an outperform vote while only 62.50% of users gave Scandium International Mining an outperform vote.
2.6% of Scandium International Mining shares are owned by institutional investors. 38.7% of Scandium International Mining shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, InMed Pharmaceuticals had 2 more articles in the media than Scandium International Mining. MarketBeat recorded 2 mentions for InMed Pharmaceuticals and 0 mentions for Scandium International Mining. Scandium International Mining's average media sentiment score of 0.00 beat InMed Pharmaceuticals' score of -0.66 indicating that Scandium International Mining is being referred to more favorably in the news media.
Summary
InMed Pharmaceuticals beats Scandium International Mining on 6 of the 10 factors compared between the two stocks.
Get Scandium International Mining News Delivered to You Automatically
Sign up to receive the latest news and ratings for SCY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Scandium International Mining Competitors List
Related Companies and Tools
This page (TSE:SCY) was last updated on 1/21/2025 by MarketBeat.com Staff
